Profitability
—
Median of the other 5: 9.1%
Return on capital: not in our data yet
return on capital
13.5%9.6%9.1%3.1%−32.8%
PARNAX LABBal PharmaAlpa LaboratoriesBALAXI PHARMACEUTICALSKrebs Biochemicals and Industries
Median of the other 5: 9.1%
BSE: APL · Healthcare · Pharmaceuticals · Market cap ₹124 Cr
· Prev close ₹141.10 · Volume 17.00 K
Company profile: not in our data yet
Return on capital: not in our data yet
Median of the other 5: 9.1%
Profit, last 4 quarters vs the 4 before: not in our data yet
Price to earnings: not in our data yet
Generated The other 4 listed peers have a median P/E of 25.7×.
Of profit came in as cash, last 5 fiscal years: not in our data yet
Held by domestic funds: not in our data yet
In 1 month: not in our data yet
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q4 FY26 (Mar 26), operating margin was 12.5%.
An earnings call transcript: not in our data yet